Status:
COMPLETED
Botox in the Healing of Surgical Wounds of the Neck
Lead Sponsor:
Nova Scotia Health Authority
Collaborating Sponsors:
Allergan
Conditions:
Scar
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The investigators hypothesize that Botox A will reduce scarring and improve healing of surgical neck wounds.
Detailed Description
Botulinum Toxin A is a toxin produced by the anaerobic bacterial species Clostridium botulinum. The toxin specifically inhibits release of the neurotransmitter Acetylcholine at synaptic junctions, thu...
Eligibility Criteria
Inclusion
- all patients referred to the ENT clinic for a thyroidectomy or parathyroidectomy
Exclusion
- patients with missing information, including demographic information
- patients lost to follow up or have been followed for less than 6 months
- patients with known allergy to lidocaine
- patients in whom botox would be contraindicated in:
- known history of neuromuscular disorders (myasthenia gravis, amyotrophic lateral sclerosis, Eaton-Lambert syndrome)
- pregnant women
- known allergy to botox, albumin
Key Trial Info
Start Date :
May 31 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01177358
Start Date
May 31 2010
End Date
May 5 2016
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Elizabeth II Hospital
Halifax, Nova Scotia, Canada, B3H 1V7